Aarey Drugs & Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022
For the six months, sales was INR 1,936.02 million compared to INR 2,321.67 million a year ago. Revenue was INR 1,950.15 million compared to INR 2,336.53 million a year ago. Net income was INR 29.19 million compared to INR 53.52 million a year ago. Basic earnings per share from continuing operations was INR 1.15 compared to INR 2.29 a year ago. Diluted earnings per share from continuing operations was INR 1.15 compared to INR 2.29 a year ago.